首页AFX • ETR
add
Carl Zeiss Meditec AG
昨日收盘价
€70.85
当日价格范围
€70.05 - €72.00
年度波幅
€54.60 - €123.75
市值
50.74亿 EUR
平均交易量
14.90万
市盈率
31.23
股息率
1.55%
主要交易所
ETR
财务信息
损益表
收入
净收入
| (EUR) | 2024年6月info | 年同比变化 |
|---|---|---|
收入 | 5.39亿 | 0.79% |
经营支出 | 2.39亿 | 11.27% |
净收入 | 3413.00万 | -62.96% |
净利润率 | 6.33 | -63.24% |
每股收益 | 0.43 | — |
息税折旧摊销前利润 | 6010.60万 | -43.58% |
有效税率 | 32.31% | — |
资产负债表
总资产
负债总额
| (EUR) | 2024年6月info | 年同比变化 |
|---|---|---|
现金及短期投资 | 1533.90万 | 24.06% |
总资产 | — | — |
负债总额 | — | — |
权益总额 | 21.07亿 | — |
发行在外的股份 | 8973.50万 | — |
市净率 | 3.03 | — |
资产回报率 | — | — |
资本回报率 | 6.08% | — |
现金流
现金净变动
| (EUR) | 2024年6月info | 年同比变化 |
|---|---|---|
净收入 | 3413.00万 | -62.96% |
来自运营的现金 | — | — |
投资现金 | — | — |
融资现金 | — | — |
现金净变动 | — | — |
自由现金流 | — | — |
简介
Carl Zeiss Meditec AG is a multinational medical technology company and subsidiary of Carl Zeiss AG. It manufactures tools for eye examinations and medical lasers as well as solutions for neurosurgery, dentistry, gynecology and oncology. Among its products are the most common tools used by ophthalmologists and optometrists.
In October 2018, Carl Zeiss Meditec won FDA premarket approval for its ReLEx Smile laser system.
Also in October 2018, Carl Zeiss Meditec announced the acquisition of Reno, Nevada-based IanTech for an undisclosed sum.
In September 2019, Carl Zeiss Meditec launched the CIRRUS 6000 at the European Society of Retina Specialists 2019 Congress. Wikipedia
CEO
成立时间
2002
总部
员工数量
4,950
